| Literature DB >> 30348154 |
Welbeck A Oumbouke1,2, Innocent Z Tia3, Antoine M G Barreaux4, Alphonsine A Koffi3, Eleanore D Sternberg4, Matthew B Thomas4, Raphael N'Guessan5,3.
Abstract
BACKGROUND: The widespread emergence of insecticide resistance in African malaria vectors remains one of the main challenges facing control programmes. Electrostatic coating that uses polarity to bind insecticide particles is a new way of delivering insecticides to mosquitoes. Although previous tests demonstrated the resistance breaking potential of this application method, studies screening and investigating the residual efficacy of a broader range of insecticides are necessary.Entities:
Keywords: Eave tubes; Electrostatic coating; Insecticide resistance; Powder-formulated insecticide; Residual efficacy; Resistance breaking
Mesh:
Substances:
Year: 2018 PMID: 30348154 PMCID: PMC6196564 DOI: 10.1186/s12936-018-2517-9
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
List of insecticides initially screened for residual performance against pyrethroid resistant Anopheles gambiae M'bé strain
| Commercial name (supplier) | Active ingredients (dose) | Chemical classes |
|---|---|---|
| Actellic (Syngenta, Switzerland) | Pyrimiphos methyl (1.6%); thiamethoxam (0.36%) | Organophosphate; neonicotinoid |
| NA | Azamethiphos (10%) | Organophosphate |
| NA | Fungus | |
| Ficam D (Bayer, Germany) | Bendiocarb (1.25%) | Carbamate |
| BISTAR 10 WP (FMC India) | Bifenthrin (10%) | Pyrethroid |
| BorActin (Rockwell labs Ltd, USA) | Orthoboric acid (99%) | Boric acid |
| Tempo Ultra (Bayer, Germany) | Beta-cyfluthrin WP (10%) | Pyrethroid |
| Spritex (Denka International BV, Barneveld, The Netherlands) | Deltamethrin (0.25%) | Pyrethroid |
| Drione (Bayer, Germany) | Pyrethrin (1%); Piperonyl | Pyrethroid; synergist |
| NA | Permethrin (25%) | Pyrethroid |
| Sevin (TechPac LLC, Atlanta) | Carbaryl (5%) | Carbamate |
Commercial names are provided for insecticides that are available on the market; NA indicates that the insecticide was an experimental formulation and not a commercially available product
Fig. 1a Photo of the components of the eave tube assay; b Picture of the experimental hut fitted with eave tubes
Fig. 2Weekly mortality rates of pyrethroid resistant Anopheles gambiae M’bé strain after exposure to insecticide treated insert using 3 min eave tube assay. Error bars indicate the confidence intervals for the different proportions on the graphs
Fig. 3Residual activity over 12 months of 10% beta-cyfluthrin (selected from initial screening) on insert against pyrethroid resistant Anopheles gambiae from M’bé. Error bars indicate the confidence intervals for the different proportions on the graphs (MAT months after treatment)
Release-recapture of pyrethroid resistant An. gambiae within enclosure at M’bé, Côte d’Ivoire
| Treatment | Total released | % recaptured (95% CI) | % immediate mortality (95% CI) | % 24 h mortality (95% CI) | % with fluorescent dust (95% CI) |
|---|---|---|---|---|---|
| Untreated insert | 395 | 90.38 [87.5–93.3] | 1.12a [0.03–2.21] | 2.8a [1.1–4.5] | – |
| 10% beta-cyfluthrin treated insert | 389 | 84.31 [80.7–87.9] | 55b [49.6–60.4] | 64b [58.8–69.2] | – |
| Fluorescent dust-treated insert | 790 | 87.6 [85.5–89.7] | – | – | 44.4 [40.7 – 48.1] |
* Values in the same column not sharing a letter superscript differ significantly (P < 0.05, GLMMs)
Fig. 4Exposure time and induced mortality of individual pyrethroid resistant Anopheles gambiae from M’bé with 10% beta-cyfluthrin treated insert. Error bars indicate the confidence intervals for the different proportions on the graphs